49 related articles for article (PubMed ID: 38673897)
21. Pancreatic Cancer: A Review.
Park W; Chawla A; O'Reilly EM
JAMA; 2021 Sep; 326(9):851-862. PubMed ID: 34547082
[TBL] [Abstract][Full Text] [Related]
22. Primary Clear Cell Carcinoma of the Pancreas: A Systematic Review.
Tannous T; Perez Rodriguez AL; Mak AW; Tannous K; Keating M
Cureus; 2021 Jun; 13(6):e15668. PubMed ID: 34150416
[TBL] [Abstract][Full Text] [Related]
23. Analysing the mechanism of mitochondrial oxidation-induced cell death using a multifunctional iridium(III) photosensitiser.
Lee C; Nam JS; Lee CG; Park M; Yoo CM; Rhee HW; Seo JK; Kwon TH
Nat Commun; 2021 Jan; 12(1):26. PubMed ID: 33397915
[TBL] [Abstract][Full Text] [Related]
24. NDUFA4L2 Regulated by HIF-1α Promotes Metastasis and Epithelial-Mesenchymal Transition of Osteosarcoma Cells Through Inhibiting ROS Production.
Xu WN; Yang RZ; Zheng HL; Jiang LS; Jiang SD
Front Cell Dev Biol; 2020; 8():515051. PubMed ID: 33330441
[TBL] [Abstract][Full Text] [Related]
25. Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology.
Bazzichetto C; Luchini C; Conciatori F; Vaccaro V; Di Cello I; Mattiolo P; Falcone I; Ferretti G; Scarpa A; Cognetti F; Milella M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266496
[TBL] [Abstract][Full Text] [Related]
26. Extracellular Vesicles as Signaling Mediators and Disease Biomarkers across Biological Barriers.
Simeone P; Bologna G; Lanuti P; Pierdomenico L; Guagnano MT; Pieragostino D; Del Boccio P; Vergara D; Marchisio M; Miscia S; Mariani-Costantini R
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260425
[TBL] [Abstract][Full Text] [Related]
27. The 2019 WHO classification of tumours of the digestive system.
Nagtegaal ID; Odze RD; Klimstra D; Paradis V; Rugge M; Schirmacher P; Washington KM; Carneiro F; Cree IA;
Histopathology; 2020 Jan; 76(2):182-188. PubMed ID: 31433515
[No Abstract] [Full Text] [Related]
28. Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma.
Lucarelli G; Rutigliano M; Sallustio F; Ribatti D; Giglio A; Lepore Signorile M; Grossi V; Sanese P; Napoli A; Maiorano E; Bianchi C; Perego RA; Ferro M; Ranieri E; Serino G; Bell LN; Ditonno P; Simone C; Battaglia M
Aging (Albany NY); 2018 Dec; 10(12):3957-3985. PubMed ID: 30538212
[TBL] [Abstract][Full Text] [Related]
29. Different approaches to modeling analysis of mitochondrial swelling.
Javadov S; Chapa-Dubocq X; Makarov V
Mitochondrion; 2018 Jan; 38():58-70. PubMed ID: 28802667
[TBL] [Abstract][Full Text] [Related]
30. The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer.
Krebs AM; Mitschke J; Lasierra Losada M; Schmalhofer O; Boerries M; Busch H; Boettcher M; Mougiakakos D; Reichardt W; Bronsert P; Brunton VG; Pilarsky C; Winkler TH; Brabletz S; Stemmler MP; Brabletz T
Nat Cell Biol; 2017 May; 19(5):518-529. PubMed ID: 28414315
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs.
Phinney DG; Di Giuseppe M; Njah J; Sala E; Shiva S; St Croix CM; Stolz DB; Watkins SC; Di YP; Leikauf GD; Kolls J; Riches DW; Deiuliis G; Kaminski N; Boregowda SV; McKenna DH; Ortiz LA
Nat Commun; 2015 Oct; 6():8472. PubMed ID: 26442449
[TBL] [Abstract][Full Text] [Related]
32. Is cancer a metabolic disease?
Coller HA
Am J Pathol; 2014 Jan; 184(1):4-17. PubMed ID: 24139946
[TBL] [Abstract][Full Text] [Related]
33. Cytoplasm and organelle transfer between mesenchymal multipotent stromal cells and renal tubular cells in co-culture.
Plotnikov EY; Khryapenkova TG; Galkina SI; Sukhikh GT; Zorov DB
Exp Cell Res; 2010 Sep; 316(15):2447-55. PubMed ID: 20599955
[TBL] [Abstract][Full Text] [Related]
34. Clear cell carcinoma of the pancreas: histopathologic features and a unique biomarker: hepatocyte nuclear factor-1beta.
Kim L; Liao J; Zhang M; Talamonti M; Bentrem D; Rao S; Yang GY
Mod Pathol; 2008 Sep; 21(9):1075-83. PubMed ID: 18536653
[TBL] [Abstract][Full Text] [Related]
35. Adenosquamous carcinoma of the pancreas with clear cell and rhabdoid components. A case report.
Jamali M; Serra S; Chetty R
JOP; 2007 May; 8(3):330-4. PubMed ID: 17495363
[TBL] [Abstract][Full Text] [Related]
36. Megamitochondria formation - physiology and pathology.
Wakabayashi T
J Cell Mol Med; 2002; 6(4):497-538. PubMed ID: 12611638
[TBL] [Abstract][Full Text] [Related]
37. BRCA2 germline mutations in familial pancreatic carcinoma.
Hahn SA; Greenhalf B; Ellis I; Sina-Frey M; Rieder H; Korte B; Gerdes B; Kress R; Ziegler A; Raeburn JA; Campra D; Grützmann R; Rehder H; Rothmund M; Schmiegel W; Neoptolemos JP; Bartsch DK
J Natl Cancer Inst; 2003 Feb; 95(3):214-21. PubMed ID: 12569143
[TBL] [Abstract][Full Text] [Related]
38. An alternative, nonapoptotic form of programmed cell death.
Sperandio S; de Belle I; Bredesen DE
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14376-81. PubMed ID: 11121041
[TBL] [Abstract][Full Text] [Related]
39. Cancer (non-endocrine) of the pancreas. A suggested classification.
Cubilla AL; Fitzgerald PJ
Monogr Pathol; 1980; 21():82-110. PubMed ID: 6261124
[No Abstract] [Full Text] [Related]
40. Clear cell carcinoma of the pancreas.
Kanai N; Nagaki S; Tanaka T
Acta Pathol Jpn; 1987 Sep; 37(9):1521-6. PubMed ID: 3687432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
